Artificial Intelligence In Pathology Market Report 2026

Artificial Intelligence In Pathology Market Overview

• Artificial Intelligence In Pathology market size has reached to $1.38 billion in 2025 • Expected to grow to $2.57 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Increasing Need For Personalized Medicine Is Driving The Growth Of The Artificial Intelligence In Pathology Market. • Market Trend: Advancements In AI-Based Multi-Tissue Cancer Detection Tools • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Artificial Intelligence In Pathology Market?

Artificial intelligence (AI) in pathology involves the use of machine learning algorithms and deep learning models to assist in analyzing medical images, identifying patterns, and diagnosing diseases. AI helps pathologists automate tasks such as slide analysis, tumor detection, and grading, improving diagnostic accuracy and efficiency. It also enables faster processing of large datasets, facilitating personalized medicine. The main components in artificial intelligence in pathology are software and scanners. Software refers to a set of programs and algorithms designed to perform specific tasks or processes, and in pathology, it is used for analyzing medical images, managing data, and supporting diagnostic and research activities. The technology utilizes various neural network types, including generative adversarial networks, convolutional neural networks, conventional neural networks, recurrent neural networks, and others. AI in pathology is applied in drug discovery, disease diagnosis and prognosis, clinical workflow, and training and education. The users of these technologies include pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic and research institutes.

What Is The Artificial Intelligence In Pathology Market Growth Forecast?

The artificial intelligence in pathology market size is expected to see rapid growth in the next few years. It will grow to $2.57 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing use of AI-assisted diagnostics, rising focus on personalized medicine, expansion of AI integration in clinical decision support, growing investments in digital healthcare infrastructure, increasing regulatory approvals for AI-based pathology tools. Major trends in the forecast period include increasing adoption of AI-based digital pathology platforms, rising use of deep learning for tumor detection, growing integration of whole slide imaging systems, expansion of predictive analytics in disease diagnosis, enhanced focus on workflow automation in pathology labs.

Global Artificial Intelligence In Pathology Market Segmentation

1) By Component: Software, Scanners 2) By Neural Network: Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks 3) By Application: Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education 4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes Subsegments: 1) By Software: Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software 2) By Scanners: Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners

What Is The Driver Of The Artificial Intelligence In Pathology Market?

The increasing need for personalized medicine is expected to propel the growth of artificial intelligence in pathology market going forward. Personalized medicine refers to tailoring medical treatment and healthcare to the individual characteristics, needs, and preferences of each patient. The increasing need for personalized medicine is due to tailor treatments to individual genetic profiles, lifestyle factors, and specific disease characteristics, thereby improving efficacy and reducing adverse effects. Artificial intelligence (AI) in pathology helps personalized medicine by enabling more accurate and efficient analysis of medical images and genetic data, thus allowing for more precise diagnosis, better identification of disease subtypes, and tailored treatment plans that align with an individual's unique biological profile. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based professional membership organisation, in 2023, the US Food and Drug Administration (FDA) approved 20 new personalized medicines, accounting for approximately 38 % of all newly approved therapeutic molecular entities marking a significant increase compared to previous years. Therefore, the increasing need for personalized medicine is driving the growth of artificial intelligence in pathology industry.

Key Players In The Global Artificial Intelligence In Pathology Market

Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.

Global Artificial Intelligence In Pathology Market Trends and Insights

Major companies operating in the artificial intelligence (AI) in pathology market are focusing on developing advanced solutions, such as multi-tissue cancer detection tools, to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes. Multi-tissue cancer detection tools using AI leverage foundation models and deep-learning algorithms to analyze digitized pathology slides, enabling detection across multiple tissue types, including rare tumors and metastatic deposits. For instance, in January 2024, Paige, a US-based digital pathology company, launched a new AI application built on its foundation model Virchow, which can detect cancer across more than 17 different tissue types. The solution is designed to assist pathologists with improved diagnostic accuracy, faster workflow efficiency, and actionable insights for personalized patient care.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Pathology Market?

In March 2023, Clarapath, a US-based medical robotics company, acquired Crosscope for an undisclosed amount. Through this acquisition, Crosscope aims to enhance its digital pathology platform by integrating advanced workflow tools and AI capabilities with Clarapath's automated tissue sectioning system, ultimately improving efficiency and accuracy in pathology laboratories. Crosscope is a US-based company that develops a digital pathology imaging platform that incorporates artificial intelligence for enhanced analysis and diagnostics in pathology.

Regional Insights

Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence In Pathology Market?

The artificial intelligence in pathology market consists of revenues earned by entities by providing services such as automated diagnostics, image analysis and interpretation, workflow optimization, and remote and telepathology. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in pathology market also includes sales of high-resolution scanners, graphics processing units (GPUs), workstations, and storage systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence In Pathology Market Report 2026?

The artificial intelligence in pathology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in pathology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.